The authors investigated the utility of an intravascular magnetic resonance (MR) contrast agent, poly-L-lysine-gadolinium diethylenetriaminepentaacetic acid (DTPA), for differentiating acutely ischemic from normally perfused myocardium with first-pass MR imaging. Hypoperfused regions, identified with microspheres, on the first-pass images displayed significantly decreased signal intensities compared with normally perfused myocardium (P < .0007). Estimates of regional myocardial blood content, obtained by measuring the ratio of areas under the signal intensityversus-time curves in tissue regions and the left ventricular chamber, averaged 0.12 mL/g ± 0.04 (n = 35), compared with a value of 0.11 mL/g ± 0.05 measured with radiolabeled albumin in the same tissue regions. To obtain MR estimates of regional myocardial blood flow, in situ calibration curves were used to transform first-pass intensity-time curves into content-time curves for analysis with a multiple-pathway, axially distributed model. Flow estimates, obtained by automated parameter optimization, averaged 1.2 mL/min/g ± 0.5 [n = 29), compared with 1.3 mL/min/g ± 0.3 obtained with tracer microspheres in the same tissue specimens at the same time. The results represent a combination of T1-weighted first-pass imaging, intravascular relaxation agents, and a spatially distributed perfusion model to obtain absolute regional myocardial blood flow and volume.
Index termsContrast agent, blood pool; Contrast enhancement; Coronary vessels, diseases, 54.76; Heart, flow dynamics; Heart, MR, 51.12143; Model, mathematical; Myocardium, blood supply, 511.12143; Myocardium, MR, 511.12143
NIH-PA Author ManuscriptNIH-PA Author Manuscript
NIH-PA Author ManuscriptA growing body of evidence supports the feasibility of evaluating myocardial perfusion with magnetic resonance (MR) imaging with contrast agents. A variety of intravascular and extracellular MR contrast agents have been studied for delineation of infarcted myocardium (1-3) and for identification of acutely ischemic and reperfused cardiac muscle (4,5). The first-pass MR imaging technique with the extracellular contrast agent gadolinium diethylenetriaminepentaacetic acid (DTPA) has been used to assess myocardial perfusion in patients at rest (6,7) and during pharmacologic stress (8,9). Although experimental (10) and patient studies have demonstrated the suitability of extracellular contrast agents for detecting hypoperfused myocardium, such agents are inherently disadvantageous for flow quantification because they are not confined to a single volume compartment within the tissue. Consequently, first-pass kinetics of an extracellular agent are determined not only by blood flow but by the intravascular and interstitial distribution volumes and by permeability across the capillary wall. This exchange between the vascular and interstitial compartments greatly complicates quantification of tissue blood flow unless it is either very fast or slow compared with flow rates (11).The objective of the present study was to...